Back
Speaker illustration

Mr Itamar Dias

University Medical Centre Groningen, Groningen (Netherlands (The))

Member of:

Heart Failure Association

Itamar - Biotechnologist & PhD Candidate in Cardio-Oncology Graduate of Rutgers University and holder of a Master's in Molecular Medicine and Innovative Treatments (MMIT) from the University of Groningen. As a PhD candidate at the University Medical Center Groningen (UMCG), I am at the forefront of cardio-oncology research. My focus lies in exploring the molecular mechanisms of cardiotoxicity through the development of an AIC 3D engineered cardiac tissue model using iPSC technology. Balancing my academic pursuits, I am deeply engaged in sports, particularly soccer, reflecting my dedication to teamwork and resilience. Eager to connect with fellow professionals and contribute to advancements in science and health.

Presentations Articles

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

Event: Heart Failure 2024

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Basic science

Access
Thumbnail

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: The immune system in the pathogenesis and treatment of cancer therapy-induced cardiovascular toxicity

Access
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources